You have 9 free searches left this month | for more free features.

irinotecan

Showing 1 - 25 of 493

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Irinotecan
  • +2 more
  • Eindhoven, Netherlands
  • +1 more
Aug 15, 2023

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

Gastric Cancer Trial (Fruquintinib, Irinotecan)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Dec 6, 2022

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Nov 13, 2022

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Nov 27, 2022

Second Line Treatment of Gastric Cancer Trial (Camrelizumab, Albumin-Bound Paclitaxel, Irinotecan)

Not yet recruiting
  • Second Line Treatment of Gastric Cancer
  • (no location specified)
Dec 20, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Irinotecan
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)

Active, not recruiting
  • Desmoplastic Small Round Cell Tumor
  • Rhabdomyosarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Metastatic Colorectal Cancer Trial (AUM001, Pembrolizumab, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Jul 13, 2022

Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

Recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • Beijing, China
  • +2 more
Apr 6, 2023

Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer Trial in Shanghai (Fluzoparib, Irinotecan)

Not yet recruiting
  • Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Feb 22, 2023

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,

Recruiting
  • Colorectal Cancer
  • +4 more
  • Fosifloxuridine Nafalbenamide
  • +4 more
  • Wichita, Kansas
  • +5 more
Jan 9, 2023

Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)

Recruiting
  • Brain Tumor, Recurrent
  • +3 more
  • Houston, Texas
    Texas Children's Cancer Center
Aug 15, 2022

Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Nice, Alpes-Maritimes, France
  • +10 more
Jan 16, 2023

Malignant Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in Sacramento, New Brunswick (RRx-001, Irinotecan)

Terminated
  • Malignant Solid Tumor
  • +2 more
  • Sacramento, California
  • +1 more
May 12, 2022